| 2005 | Alf Lamprecht, Hiromitsu Yamamoto, Hirofumi Takeuchi, Yoshiaki Kawashima: A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles. In: Journal of Controlled Release , 2005, 337-346 |
|---|
| 2005 | Alf Lamprecht, Hiromitsu Yamamoto, Nathalie Ubrich, Hirofumi Takeuchi, Philippe Maincent, Yoshiaki Kawashima: FK506 microparticles mitigate experimental colitis with minor renal calcineurin suppression.. In: Pharmaceutical Research , 2005, 193-199 |
|---|
| 2005 | Alf Lamprecht, Hiromitsu Yamamoto, Hirofumi Takeuchi, Yoshiaki Kawashima: Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats. In: Journal of Pharmacology and Experimental Therapeutics, 2005, 1-7 |
|---|
| 2005 | Alf Lamprecht, Hiromitsu Yamamoto, Hirofumi Takeuchi, Yoshiaki Kawashima: Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release. . In: European Journal of Pharmaceutics and Biopharmaceutics, 2005, 367-371 |
|---|
| 2004 | Alf Lamprecht, Hiromitsu Yamamoto, Hirofumi Takeuchi, Yoshiaki Kawashima: Design of pH-sensitive microspheres for the colon delivery of the immune suppressive drug tacrolimus. In: European Journal of Pharmaceutics and Biopharmaceutics, 2004, 37-43 |
|---|
| 2004 | Alf Lamprecht, Hiromitsu Yamamoto, Hirofumi Takeuchi, Yoshiaki Kawashima: pH-sensitive microsphere delivery increases oral bioavailability of calcitonin. In: Journal of Controlled Release, 2004, 1-9 |
|---|
| 2003 | Alf Lamprecht, Hiromitsu Yamamoto, Hirofumi Takeuchi, Yoshiaki Kawashima: Microsphere design for the colonic delivery of 5-fluorouracil. In: Journal of Controlled Release, 2003, 313-322 |
|---|
